AUG 02, 2018 6:00 AM PDT

Chronic Infections Outsmart the Immune System

WRITTEN BY: Caitlin Williams

Many chronic infections evade the immune system’s defenses so that it can remain comfortably in the host mooching off our bodies. A recent study in Cell Reports looked at how the parasite that causes visceral leishmaniasis, also known as kala-azar or black fever, escapes the host’s defenses. Visceral leishmaniasis, a potentially lethal chronic disease, is the second leading cause of death by parasitic infection. It is caused by the Leishmania species of protozoan parasite and transmitted to humans by the bites of female sandflies. In 2015 the World Health Organization (WHO) reported 300,000 estimated annual cases with over 20,000 deaths each year due to visceral leishmaniasis. Of these cases, 90% were reported to occur in six countries: Bangladesh, Brazil, Ethiopia, India, South Sudan and Sudan. Onset can be chronic or acute, with incubation of weeks to months, and it affects internal organs such as the spleen, liver, and bone marrow.

High power image of nuclei with amastigote forms of Leishmaniasis. Source: Calicut Medical COllege

Interferon-gamma, or type II interferon, is a cytokine essential to innate and adaptive immunity against infections. Interferon-gamma has immunostimulatory and immunomodulatory effects and is produced by natural killer cells in the innate response and T cells CD4 and CD8 during the adaptive immune response. During visceral leishmaniasis, CD4 T cells expressing interferon-gamma appear later in infection and in smaller numbers than expected, but the recent study by Dr. Simona Stager’s team at the Institute National de la Recherche Scientifique (INRS) has shown that the lack of T cells is due to the protective cells dying. To further study this phenomenon they looked at previously identified transcription factors, proteins that modulate the activity of one or more genes, that were present but unusual for CD4 T cells. The specific transcription factor detected, IRF-5, is known for its role in innate immunity but not CD4 T cells.

The study of IRF-5 showed that it leads CD4 cells to self-destruct due to tissue destruction. Previously unknown signals in CD4 cells are activated when tissue is destroyed, causing them to die following a series of reactions that are not fully understood. The mechanism behind this signaling begins with Toll-like Receptor 7 (TLR7), which is usually activated in innate immune cells when a pathogen is recognized. During chronic inflammation cellular residues present after tissue destruction activates TLR7 in CD4 cells. This activation leads to expression of IRF-5, which then increases expression of Death Receptor 5 (DR5) and caspase 8, which leads to cell death. The white blood cells involved in the attack are eliminated by the biological process of the host and not the parasite, allowing the parasite to be protected and sustain a chronic infection.

This mechanism may play a role with other diseases that lead to chronic infection and inflammation. The newly discovered link between chronic inflammation induction of CD4 T cell death by the TLR7 and IRF-5 pathways could lead to new treatment options. A better understanding of this work and the cellular activity induced by IRF-5 in immune cells could reveal new therapeutic targets for visceral leishmaniasis and other chronic inflammatory diseases.

To learn more about leishmaniasis watch the video below!

World Health Organization, Center for Disease Control

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
DEC 17, 2020
Immunology
A Peanut a Day Keeps Allergies Away
DEC 17, 2020
A Peanut a Day Keeps Allergies Away
Canadian researchers have made a breakthrough for children with peanut allergies: immunotherapy that when taken daily fo ...
DEC 15, 2020
Immunology
Immunity-Boosting: Is It Real?
DEC 15, 2020
Immunity-Boosting: Is It Real?
The question everyone tries to find an answer to in the winter season is how can we improve our immunity to fight any in ...
DEC 27, 2020
Immunology
Thymus Transplantation?! It Could be Possible!
DEC 27, 2020
Thymus Transplantation?! It Could be Possible!
The thymus is an essential organ of the lymphatic system; it is responsible for developing mature T cells. T c ...
JAN 06, 2021
Immunology
Probiotic Boosters Are Lifesavers for Preterm Babies
JAN 06, 2021
Probiotic Boosters Are Lifesavers for Preterm Babies
When administered shortly after birth, a recent study has found that the supplementation combo of probiotics and prebiot ...
Loading Comments...